Author:
Matsuki Takashi,Kawakita Daisuke,Takahashi Hideaki,Okada Takuro,Sakai Akihiro,Ueki Yushi,Tsuge Hiroshi,Hanyu Kenji,Momiyama Kaho,Shodo Ryusuke,Yamauchi Mayu,Asako Yukiko,Hirai Hideaki,Nagao Toshitaka,Tada Yuichiro
Funder
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 71, 209249 (2021).
2. El-Naggar, A., Chan, J. K. C. & Grandis, J. WHO classification of head neck tumours, 4th edition, volume 9; 7 tumours of salivary glands. World Health Organization 2017: pp 159. (2017).
3. Geiger, J. L. et al. Management of salivary gland malignancy: ASCO guideline. J. Clin. Oncol. Official J Am. Soc. Clin. Oncol. 39, 1909–1941 (2021).
4. van Herpen, C. et al. Salivary gland cancer: ESMO-European reference network on rare adult solid cancers (EURACAN) clinical practice guideline for diagnosis, treatment and follow-up. ESMO Open. 7, 100602 (2022).
5. Takahashi, H. et al. Phase II trial of trastuzumab and docetaxel in patients with human epidermal growth factor receptor 2-positive salivary duct carcinoma. J. Clin. Oncol. Official J. Am. Soc. Clin. Oncol. 37, 125–134 (2019).